Is QBE Insurance Group Ltd headed for disaster this reporting period?

Shares of QBE Insurance Group Ltd (ASX:QBE) have been heavily sold off recently.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors don't seem to have much faith in QBE Insurance Group Ltd (ASX: QBE) as we head towards the insurers full year report, expected to be out on the 23rd of February.

QBE shares have lost 27% of their value in the past six months and fell from highs of $15 per share earlier this year; although they are down only 8% in the past twelve months. It seems investors are doubting the company's upcoming report, questioning whether management can streamline the business as they have claimed.

The bad

In its recent 3rd quarter trading update, QBE confirmed that its guidance for a combined operating ratio of 94-95% was unchanged, with the final figure expected to be towards the top end (higher is worse) of guidance. The insurance profit margin would be towards the bottom end (higher is better) of the previously announced 8.5%-10%.

Previously, in 2014, QBE had a combined operating ratio of 96.1% and insurance margins of 7.6% so 2015's results look to be a measurable improvement.

The company's claims ratio continues to remain under pressure as growth in its premiums are slower than the rate of inflation in the ANZ and North American regions.

The good

QBE has announced an increase in its dividend payout ratio, to a maximum of 65% of cash profit for the interim of 2016 and beyond. Given that QBE made average earnings of around 2.7% on its investment portfolio in the 2014 financial year, returning the cash to shareholders is a sound move.

On the plus side, growth assets comprised a significantly larger portion of QBE's portfolio in 2014 than they did in 2013 and hopefully management has maintained that focus on growth throughout the 2015 financial year.

Additionally, the vast majority of QBE's interest-earning portfolio comes to maturity in the next twelve months, giving the company the opportunity to look for higher returns given the recent rate rise in the US.

Management also claims there is room to improve its expense ratio, as this is currently some 2-3% higher than its global peers. A further $100m in cost savings is targeted in the next financial year, supported by a lift in IT services and processing efficiency. This could mean a meaningful lift in earnings even without business growth.

A targeted approach to customer retention combined with investment in emerging markets like the Philippines is expected to deliver organic premium growth of 3-4% per annum over the next few years. I have written previously on the benefits of emerging markets and customer retention for insurers, and these initiatives are solid step forwards for QBE.

Well, should I buy it? 

I had the chance to buy QBE today as it fell below $10 – but I chose to write this article instead. So perhaps the company is not a screaming bargain, but neither is it priced for a highly successful future and there is certainly scope for upside from today's prices if management can follow through on its identified areas that need improvement.

I believe investors looking for a reliable dividend payer with the potential for steady earnings growth could do a lot worse than to add QBE to their portfolio at today's prices.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »